Priority Review Vouchers: Coartem And The Importance Of Perceptions
Executive Summary
The future of the newly enacted priority review voucher incentive program depends heavily on how the first products to qualify for the award are perceived, BIO Ventures for Global Health CEO Christopher Earl told FDC-Windhover's FDA/CMS Summit for Biopharma Executives Dec. 4